DIALYSIS · CCN 332651

DaVita Celia Dill Dialysis Center

CARMEL, NY 10512

DialysisProfitDaVita
$6.7M
TOTAL REVENUE
33.8%
OPERATING MARGIN
4 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.7M
Total costs
$4.4M
Operating income (rev − costs)
$2.3M
Operating margin
33.8%
Total charges
$6.5M
Total treatments
13,587
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.7277—
Fistula Rate
DFC_FISTULA_RATE
71.399—
Five Star Rating
DFC_FIVE_STAR
4——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
120.986—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.49——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1199—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
17.1386—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
1772—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
26.652—
Standardized ED Visits Ratio
DFC_SEDR
0.4851—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
23.241—